ENSC   $0.6096  11.44% Market Closed

Ensysce Biosciences, Inc.
Total Cash 1.04M
totalCashPerShare 0.123
EBITDA
Total Debt 454.46K
quickRatio 0.97
currentRatio 1.883
Total Revenue 1.44M
debtToEquity 30.72
Revenue/Share 0.274
ROA -1.3194001
ROE -4.27887
grossProfits
freeCashflow -5.39M
operatingCashflow -9.78M
earningsGrowth
revenueGrowth -0.629
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -10.756181
profitMargins 0.0
enterpriseValue 3.74M
forwardPE -0.60472524
floatShares 7.57M
sharesOutstanding 14.91M
sharesShort 113.06K
sharesShortPriorMonth 203.29K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.12%
Short Ratio help_outline 0.31%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.222
Price To Book help_outline 2.48
earningsQuarterlyGrowth
netIncomeToCommon -11.28M
trailingEps -2.84%
forwardEps -0.91%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.29 3Q 2024
institutionsCount 11
lastUpdated Nov. 7, 2024, 5:10 a.m.